跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
姜 廣興
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學臺北心臟醫學研究中心
https://orcid.org/0000-0003-0376-9862
電子郵件
steve.cn
msa.hinet
net
h-index
386
引文
9
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2008
2024
每年研究成果
概覽
指紋
網路
研究成果
(25)
類似的個人檔案
(6)
指紋
查看啟用 Kuang-Hsing Chiang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Mouse
77%
Advanced Glycation End Product Receptor
61%
Neovascularization (Pathology)
61%
Albuminuria
61%
Anti-Inflammatory Drug
61%
Heart Infarction
55%
Microalbuminuria
46%
Cardiovascular Disease
43%
Cohort Study
41%
Acetic Acid Ethyl Ester
41%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
38%
Chronic Obstructive Lung Disease
37%
Antioxidant
36%
Advanced Glycation End Product
34%
Essential Hypertension
33%
Biological Marker
33%
Heparin Cofactor II
30%
Rivaroxaban
30%
HMG-CoA
30%
Reperfusion Injury
30%
Bilirubin
30%
Oxidoreductase
30%
Endothelial Nitric Oxide Synthase
30%
Porcine Model
30%
Heart Ventricle Arrhythmia
30%
Dipeptidyl Peptidase IV Inhibitor
30%
Rat Model
30%
Chemokine Receptor CXCR4 Antagonist
30%
Fragility Fracture
30%
Toll Like Receptor 4
30%
Porphyromonas gingivalis
30%
Microparticle
30%
Lipocortin 5
30%
In-Stent Restenosis
30%
microRNA
30%
Antibiotic Agent
30%
Aldosterone
30%
Atrial Fibrillation
30%
Adiponectin
30%
Nitric Oxide Synthase
30%
Angiotensin
30%
Vaccination Policy
30%
Renin
30%
Inonotus Obliquus
30%
Orthosiphon
30%
Osteoarthritis
30%
Diabetic Nephropathy
30%
Streptozotocin
30%
Polysaccharide
30%
Medicine and Dentistry
Cardiovascular System
100%
Acute Heart Infarction
61%
Coronary Artery
47%
Cardiovascular Disease
37%
Influenza Vaccination
30%
Heparin Cofactor II
30%
Chronic Obstructive Pulmonary Disease
30%
Dipeptidyl Peptidase-4 Inhibitor
30%
Nitric Oxide Synthase
30%
Endothelial Function
30%
Endothelial Progenitor Cell
30%
Advanced Glycation End Product Receptor
30%
Heart Ventricle Arrhythmia
30%
Pacemaker Implantation
30%
Porphyromonas gingivalis
30%
microRNA
30%
Ambulatory Blood Pressure
30%
Arterial Stiffness
30%
Permanent Pacemaker
30%
Endothelial Cell
30%
Biological Marker
30%
Blood Pressure
30%
Toll Like Receptor 4
30%
Antibiotics
30%
In-Stent Restenosis
30%
Adiponectin
30%
Angiogenesis
25%
Hazard Ratio
21%
Endothelial Nitric Oxide Synthase
20%
Device Infection
15%
Sudden Death
15%
Cell Adhesion Molecule
13%
Diabetes
13%
Percutaneous Coronary Intervention
12%
Hindlimb
10%
Limb Ischemia
10%
Critical Limb Ischemia
10%
Coronary Artery Disease
10%
Infection
10%
Hematoma
10%
Brain Ischemia
10%
Thrombosis
10%
microRNA 24
8%
Apoplexy
8%
Odds Ratio
8%
Coronary Artery Bypass Graft
7%
Revascularization
7%
Volunteer
7%
Physician
7%
Surgeon
7%
Biochemistry, Genetics and Molecular Biology
TLR4
61%
Hypercholesterolemia
35%
Endothelial Progenitor Cell
30%
Bilirubin Blood Level
30%
Cell Level
30%
GroEL
30%
CD31
30%
Overall Survival
30%
Renin Angiotensin Aldosterone System
30%
Cohort Study
30%
Adiponectin
30%
Porphyromonas gingivalis
30%
Annexin
30%
Haptoglobin
30%
Eotaxin
30%
MicroRNA
30%
Clinical Study
14%
Cell Adhesion Molecule
10%
MiR-132
10%
Transcription Regulation
10%
Haemophilia
10%
Hyperlipidemia
10%
RNA-binding Protein
8%
Messenger RNA
8%
Mouse
7%
ICD-9
7%
Eicosanoid Receptor
6%
P38 Mitogen-Activated Protein Kinases
5%
Signal Transduction
5%
C-Jun N-Terminal Kinases
5%
Scavenger Receptor
5%